Abstract
There is current scientific and legal controversy about sports competition eligibility regulations for transgender athletes. To better understand and contextualize the effect of androgen-suppression treatment on swimming performance, we compared the gender-related differences in performance of a transgender swimmer who competed in both the male and female NCAA (collegiate) categories to the sex-related differences in performance of world and national class swimmers. These data demonstrate that the gender-related differences in middle distance freestyle performances of a transgender woman are smaller than the observed sex-related differences in performance of top athletes. Our analysis may be useful as a framework for regulators considering participation guidelines which promote fair competition for all athletes, whether cisgender or transgender.
One-Sentence Summary Recent outstanding performances by a transgender woman swimmer are faster than predictions based on historic sex-related differences in swimming performance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding to declare.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Swimming times from long course (50m pool), short course meters (25m pool), and short course yards (25-yard pool) were downloaded from the USA Swimming Database (https://www.usaswimming.org/times/ncaa/ncaa-division-i) for top 25 NCAA times and from the International Swimming Federation (FINA) Database (https://www.fina.org/swimming/rankings) for top 200 World record times.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All individual data is available in the online databases listed in the text and group data is available in the main text.
